TY - JOUR
T1 - Effect of Age and Sex on Outcomes After Stenting or Bypass Surgery in Left Main Coronary Artery Disease
AU - for the IRIS-MAIN Registry Investigators
AU - Park, Hanbit
AU - Ahn, Jung Min
AU - Yoon, Yong Hoon
AU - Kwon, O.
AU - Lee, Kyusup
AU - Kang, Do Yoon
AU - Lee, Pil Hyung
AU - Lee, Seung Whan
AU - Park, Seong Wook
AU - Park, Duk Woo
AU - Park, Seung Jung
N1 - Publisher Copyright:
© 2019 Elsevier Inc.
PY - 2019/9/1
Y1 - 2019/9/1
N2 - Age and sex contribute to determining coronary revascularization strategies for patients with left main coronary artery (LMCA) disease. We examined age- and sex-related differences in comparative outcomes after percutaneous coronary intervention (PCI) or coronary-artery bypass grafting (CABG) for LMCA disease. A total of 4,001 patients with LMCA disease (men, n = 3,100, women, n = 901) who underwent PCI (n = 2,615) or CABG (n = 1,386) from the Interventional Research Incorporation Society-Left MAIN Revascularization registry were analyzed. Patients were stratified into subgroups according to the tertiles of age (<60 years, 60 to 69 years, and ≥70 years) and sex. The primary outcome was the composite of death from any cause, myocardial infarction, or stroke. During the median 6.3 years of follow-up, the adjusted risks for primary outcome after PCI relative to CABG were similar in patients aged <60 years (hazard ratio [HR]: 0.64, 95% confidence interval [CI]: 0.35 to 1.16), 60 to 69 years (HR: 1.21; 95% CI: 0.82 to 1.80), and ≥70 years (HR: 0.90; 95% CI: 0.66 to 1.22) with no significant age-related interactions (Pinteraction = 0.57). The primary outcome risks following PCI versus CABG were similar between male (HR: 0.92; 95% CI: 0.72 to 1.17) and female (HR: 0.89; 95% CI: 0.52 to 1.50) (Pinteraction = 0.65). Significant interactions were absent for age or sex and revascularization type for all-cause mortality (Pinteraction = 0.34 for age and Pinteraction = 0.99 for sex), repeat revascularization (Pinteraction = 0.10 for age and Pinteraction = 0.65 for sex), and major adverse cardiac or cerebrovascular events (Pinteraction = 0.29 for age and Pinteraction = 0.30 for sex). In conclusion, there were no significant age- or sex-related differences in comparative outcomes after PCI or CABG for LMCA disease.
AB - Age and sex contribute to determining coronary revascularization strategies for patients with left main coronary artery (LMCA) disease. We examined age- and sex-related differences in comparative outcomes after percutaneous coronary intervention (PCI) or coronary-artery bypass grafting (CABG) for LMCA disease. A total of 4,001 patients with LMCA disease (men, n = 3,100, women, n = 901) who underwent PCI (n = 2,615) or CABG (n = 1,386) from the Interventional Research Incorporation Society-Left MAIN Revascularization registry were analyzed. Patients were stratified into subgroups according to the tertiles of age (<60 years, 60 to 69 years, and ≥70 years) and sex. The primary outcome was the composite of death from any cause, myocardial infarction, or stroke. During the median 6.3 years of follow-up, the adjusted risks for primary outcome after PCI relative to CABG were similar in patients aged <60 years (hazard ratio [HR]: 0.64, 95% confidence interval [CI]: 0.35 to 1.16), 60 to 69 years (HR: 1.21; 95% CI: 0.82 to 1.80), and ≥70 years (HR: 0.90; 95% CI: 0.66 to 1.22) with no significant age-related interactions (Pinteraction = 0.57). The primary outcome risks following PCI versus CABG were similar between male (HR: 0.92; 95% CI: 0.72 to 1.17) and female (HR: 0.89; 95% CI: 0.52 to 1.50) (Pinteraction = 0.65). Significant interactions were absent for age or sex and revascularization type for all-cause mortality (Pinteraction = 0.34 for age and Pinteraction = 0.99 for sex), repeat revascularization (Pinteraction = 0.10 for age and Pinteraction = 0.65 for sex), and major adverse cardiac or cerebrovascular events (Pinteraction = 0.29 for age and Pinteraction = 0.30 for sex). In conclusion, there were no significant age- or sex-related differences in comparative outcomes after PCI or CABG for LMCA disease.
UR - https://www.scopus.com/pages/publications/85068497367
U2 - 10.1016/j.amjcard.2019.05.061
DO - 10.1016/j.amjcard.2019.05.061
M3 - Article
C2 - 31301759
AN - SCOPUS:85068497367
SN - 0002-9149
VL - 124
SP - 678
EP - 687
JO - American Journal of Cardiology
JF - American Journal of Cardiology
IS - 5
ER -